Market Place
Sourcing Support
Glenmark Shifts to Direct U.S. Commercialization of RYALTRIS
01 Apr 2026 //
PR NEWSWIRE
Glenmark Canada Launches Men`s GLN-Minoxidil 5% Foam
01 Apr 2026 //
PR NEWSWIRE
Indian Pharma Market Grew 10.2% YoY In January 2026
17 Feb 2026 //
INDPHARMAPOST
Indian Pharma May Take AI Pill To Cut Time And Costs In Drug R&D
17 Feb 2026 //
ECONOMICTIMES
Glenmark Acquires Exclusive Multi-Regional Rights To Aumolertinib
17 Dec 2025 //
INDPHARMAPOST
Glenmark Launches Fixed-Dose Triple Therapy For COPD
26 Nov 2025 //
ECONOMICTIMES
Glenmark Posts 72.2% Jump In Q2 FY Net Profit At Rs. 610.4 Cr YoY
16 Nov 2025 //
INDPHARMAPOST
Glenmark Secures China Approval For Ryaltris
10 Nov 2025 //
INDPHARMAPOST
Glenmark, Hengrui ink $1.1B deal for HER2 ADC
24 Sep 2025 //
FIERCE PHARMA
Glenmark Eyes 70% Branded Portfolio by 2030, Drug Focus
17 Jul 2025 //
ECONOMICTIMES
Glenmark Launches Nutrition Project in Emali, Kenya
26 Jun 2025 //
PR NEWSWIRE
Glenmark Pharma to launch DCGI-approved Brukinsa in India
11 Jun 2025 //
INDPHARMAPOST
Glenmark Pharma reports Q4 FY25 PAT at Rs. 346.6 Cr
24 May 2025 //
INDPHARMAPOST
Sanofi puts insulin brand Lantus up for sale, eyes Rs 2,000 cr
15 Apr 2025 //
ECONOMICTIMES
Anurag Mantri appointed as President of Glenmark Pharmaceuticals
08 Apr 2025 //
INDPHARMAPOST
Glenmark receives ANDA approval for Olopatadine ophthalmic solution
21 Mar 2025 //
INDPHARMAPOST
Glenmark Settles U.S. Antitrust Lawsuits for $7M
24 Feb 2025 //
BUSINESS STD
Glenmark Pharma reports Q3 FY25 PAT at Rs. 348 Cr
17 Feb 2025 //
INDPHARMAPOST
India`s Glenmark Pharma Misses Profit Estimates In Q3
14 Feb 2025 //
REUTERS
Glenmark, Cosmo get MHRA nod to acne treatment in UK
10 Feb 2025 //
BUSSINESS STD
Glenmark share rises 2% as unit launches blood clotting drug
21 Jan 2025 //
BUSINESS STD
Glenmark Pharm launch of coagulation disorder drug Phytonadione
21 Jan 2025 //
BUSINESS STD
Glenmark Pharma Shares Up 2% on Rolling Out Lacosamide Solution
16 Dec 2024 //
BUSINESS STD
Glenmark to focus on becoming branded company
19 Nov 2024 //
ECONOMICTIMES
Glenmark arm recalls products in US for manufacturing issues
13 Oct 2024 //
ECONOMICTIMES
Glenmark to pay USD 25 mn as part of settlement with US authorities
05 Sep 2024 //
ECONOMICTIMES
Glenmark Launches OTC Olopatadine Hydrochloride Ophthalmic Solution
19 Aug 2024 //
PR NEWSWIRE
Glenmark Therapeutics launches Olopatadine Hydrochloride Ophthalmic Solution USP
19 Aug 2024 //
INDIANPHARMAPOST
Glenmark Pharma reports Q1 FY25 consolidated PAT at Rs. 340.2 Cr
15 Aug 2024 //
INDIANPHARMAPOST
Glenmark Pharma gets USFDA nod for seizure treatment drug
17 Jul 2024 //
MONEYCONTROL
Glenmark and IADVL undertake awareness campaign to support Vitiligo in India
26 Jun 2024 //
PHARMABIZ
Glenmark Pharma concludes Hypertension Awareness Month in India
29 May 2024 //
PHARMABIZ
Glenmark amplifies Nationwide Heart Health ‘India First Heart First’ campaign
18 May 2024 //
PHARMABIZ
Glenmark receives US FDA approval for brimonidine tartrate and timolol maleate
17 May 2024 //
PHARMABIZ
Glenmark launches next phase of ‘India First Heart First’ campaign
17 May 2024 //
INDINPHARMAPOST
Delhi High Court seeks response from govt, NPPA on Glenmark`s plea
09 Apr 2024 //
ECONOMIC TIMES
Maharashtra FDA begins probe stickering & mislabelling on Glenmark`s drug Telma
05 Apr 2024 //
DERUG CONTROL
Glenmark Pharma posts Q3 FY24 net loss of Rs. 331 Cr
15 Feb 2024 //
INDIAN PHARMA POST
India`s Glenmark Pharma posts loss for Q3 as remediation cost weighs
14 Feb 2024 //
REUTERS
Glenmark partners with Pfizer to launch abrocitinib in India
31 Jan 2024 //
ECONOMIC TIMES
Ichnos and Glenmark take a collaborative leap
30 Jan 2024 //
PR NEWSWIRE
Glenmark bags subcutaneous checkpoint inhibitor rights
25 Jan 2024 //
FIERCE BIOTECH
Glenmark inks licensing pact with Jiangsu Alphamab, 3D Medicines for cancer drug
25 Jan 2024 //
ECONOMIC TIMES
Glenmark launches antidiabetic drug in India
03 Jan 2024 //
ECONOMIC TIMES
DKSH and Glenmark Partner to Enrich People’s Lives in Vietnam
28 Nov 2023 //
PRESS RELEASE
Glenmark Pharma reports Q2 FY24 loss at Rs. 62 Cr
13 Nov 2023 //
INDIAN PHARMA POST
India`s Glenmark Pharma posts Q2 loss on exceptional legal costs
10 Nov 2023 //
REUTERS
Glenmark to launch Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin
18 Oct 2023 //
INDIAN PHARMA POST
Cosmo and Glenmark announce the signing of Agreements for Winlevi
27 Sep 2023 //
PR NEWSWIRE
Glenmark to pay $30M in antitrust settlement in US over cholesterol drug pricing
23 Aug 2023 //
ECONOMICS TIMES
HC restrains Glenmark from selling asthma drug under `Indamet` name
04 Jul 2023 //
ECONOMIC TIMES
Miller Law& Motley Ric Announce a Proposed Settlement Zetia Antitrust Litigation
27 Jun 2023 //
PR NEWSWIRE
Glenmark reports Rs 403 crore loss in Q4FY23
19 May 2023 //
ECONOMIC TIMES
Merck, Glenmark put their Zetia antitrust case to bed
25 Apr 2023 //
FIERCE PHARMA
Glenmark Enters Into $48 Mn Settlement With Plaintiffs Against Lawsuit In US
21 Apr 2023 //
BWHEALTHCAREWORLD
Glenmark Pharma weighs selling stake in Glenmark Life in bid to reduce debt
11 Apr 2023 //
ECONOMIC TIMES
Glenmark receives acceptance from U.S. FDA on its IND application for GRC 54276
16 Mar 2023 //
PR NEWSWIRE
Glenmark gets USFDA nod to begin trials for potential cancer drug
16 Mar 2023 //
ECONOMIC TIMES
Glenmark and Cediprof Announce Agreement in the United States
09 Mar 2023 //
PR NEWSWIRE
Glenmark and Cediprof announce exclusive distribution agreement in US
09 Mar 2023 //
ECONOMIC TIMES
